Using the weekly chart, June's price action shows a break above a long-term ascending trendline (purple line).
The trendline was formed in September 2019,[1] and after a hefty drop in October, took time to rebuild momentum.
In February 2020, the scene was set for a new test.[2] While the price reached an all-time high above $40, it quickly dropped in light of the panic selling with COVID-19.
During April, panic selling flipped into FOMO-style buying, which pushed beyond February's all time high.
A key test emerged in the second half of May, when the price reached $45 and was ready to retest the existing trendline.
When the irresistible force (the uptrend) met the immovable object (the trendline), the former won.[3]
The first two weeks of June saw some momentary selling pressure back towards the trendline. Although intraweek trade never went lower than the trendline, it created a conspicuous spinning top two weeks ago.
Was that candlestick the beginning of the end? Apparently not - it was topped by last week's tall green candle, being the eighth in a row.
For June so far, that makes for three consecutive weeks above the trendline, and no trades below it.[4]
- Forums
- Charts
- APT Chart
Using the weekly chart, June's price action shows a break above...
-
-
- There are more pages in this discussion • 2,779 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add APT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online